184 related articles for article (PubMed ID: 37268865)
1. RNA Sequencing of Intraoperative Peritumoral Tissues Reveals Potential Pathways Involved in Glioma-Related Seizures.
Kumar K; Dubey V; Zaidi SS; Tripathi M; Siraj F; Sharma MC; Chandra PS; Doddamani R; Dixit AB; Banerjee J
J Mol Neurosci; 2023 Jun; 73(6):437-447. PubMed ID: 37268865
[TBL] [Abstract][Full Text] [Related]
2. Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures.
Feyissa AM; Carrano A; Wang X; Allen M; Ertekin-Taner N; Dickson DW; Jentoft ME; Rosenfeld SS; Tatum WO; Ritaccio AL; Guerrero-Cázares H; Quiñones-Hinojosa A
Epilepsy Res; 2021 Jul; 173():106618. PubMed ID: 33765507
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic profiling of nonneoplastic cortical tissues reveals epileptogenic mechanisms in dysembryoplastic neuroepithelial tumors.
Kumar K; Banerjee Dixit A; Tripathi M; Dubey V; Siraj F; Sharma MC; Lalwani S; Chandra PS; Banerjee J
Funct Integr Genomics; 2022 Oct; 22(5):905-917. PubMed ID: 35633443
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic profiling of human peritumoral neocortex tissues revealed genes possibly involved in tumor-induced epilepsy.
Niesen CE; Xu J; Fan X; Li X; Wheeler CJ; Mamelak AN; Wang C
PLoS One; 2013; 8(2):e56077. PubMed ID: 23418513
[TBL] [Abstract][Full Text] [Related]
5. Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
Wang YH; Huang TL; Chen X; Yu SX; Li W; Chen T; Li Y; Kuang YQ; Shu HF
J Neuropathol Exp Neurol; 2021 Jan; 80(2):137-149. PubMed ID: 33382873
[TBL] [Abstract][Full Text] [Related]
6. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
7. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
8. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
9. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Jiewen L; Shu J; Qing M
Neurol Sci; 2017 Jan; 38(1):61-66. PubMed ID: 27646413
[TBL] [Abstract][Full Text] [Related]
11. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
[TBL] [Abstract][Full Text] [Related]
12. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.
Wang Y; Fan X; Zhang W; Zhang C; Wang J; Jiang T; Wang L
J Neurooncol; 2015 Feb; 121(3):609-16. PubMed ID: 25511798
[TBL] [Abstract][Full Text] [Related]
14. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
[TBL] [Abstract][Full Text] [Related]
15. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiles for insular low-grade gliomas with putamen involvement.
Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
[TBL] [Abstract][Full Text] [Related]
17. Tumoral epileptogenicity: how does it happen?
Pallud J; Capelle L; Huberfeld G
Epilepsia; 2013 Dec; 54 Suppl 9():30-4. PubMed ID: 24328869
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
19. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
20. Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma.
Lin H; Yang Y; Hou C; Huang Y; Zhou L; Zheng J; Lv G; Mao R; Chen S; Xu P; Zhou Y; Wang P; Zhou D
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33969375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
